Literature DB >> 7509448

Structural and functional aspects of the multiplicity of Neu differentiation factors.

D Wen1, S V Suggs, D Karunagaran, N Liu, R L Cupples, Y Luo, A M Janssen, N Ben-Baruch, D B Trollinger, V L Jacobsen.   

Abstract

We used molecular cloning and functional analyses to extend the family of Neu differentiation factors (NDFs) and to explore the biochemical activity of different NDF isoforms. Exhaustive cloning revealed the existence of six distinct fibroblastic pro-NDFs, whose basic transmembrane structure includes an immunoglobulin-like motif and an epidermal growth factor (EGF)-like domain. Structural variation is confined to three domains: the C-terminal portion of the EGF-like domain (isoforms alpha and beta), the adjacent juxtamembrane stretch (isoforms 1 to 4), and the variable-length cytoplasmic domain (isoforms a, b, and c). Only certain combinations of the variable domains exist, and they display partial tissue specificity in their expression: pro-NDF-alpha 2 is the predominant form in mesenchymal cells, whereas pro-NDF-beta 1 is the major neuronal isoform. Only the transmembrane isoforms were glycosylated and secreted as biologically active 44-kDa glycoproteins, implying that the transmembrane domain functions as an internal signal peptide. Extensive glycosylation precedes proteolytic cleavage of pro-NDF but has no effect on receptor binding. By contrast, the EGF-like domain fully retains receptor binding activity when expressed separately, but its beta-type C terminus displays higher affinity than alpha-type NDFs. Likewise, structural heterogeneity of the cytoplasmic tails may determine isoform-specific rate of pro-NDF processing. Taken together, these results suggest that different NDF isoforms are generated by alternative splicing and perform distinct tissue-specific functions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7509448      PMCID: PMC358549          DOI: 10.1128/mcb.14.3.1909-1919.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  34 in total

Review 1.  Transforming growth factor-alpha. A model for membrane-anchored growth factors.

Authors:  J Massagué
Journal:  J Biol Chem       Date:  1990-12-15       Impact factor: 5.157

Review 2.  Oncogenes and signal transduction.

Authors:  L C Cantley; K R Auger; C Carpenter; B Duckworth; A Graziani; R Kapeller; S Soltoff
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

Review 3.  Signal transduction by receptors with tyrosine kinase activity.

Authors:  A Ullrich; J Schlessinger
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

4.  Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.

Authors:  R Lupu; R Colomer; G Zugmaier; J Sarup; M Shepard; D Slamon; M E Lippman
Journal:  Science       Date:  1990-09-28       Impact factor: 47.728

5.  Structure-function analysis of epidermal growth factor: site directed mutagenesis and nuclear magnetic resonance.

Authors:  T J Dudgeon; R M Cooke; M Baron; I D Campbell; R M Edwards; A Fallon
Journal:  FEBS Lett       Date:  1990-02-26       Impact factor: 4.124

6.  Molecular cloning and expression of an additional epidermal growth factor receptor-related gene.

Authors:  G D Plowman; G S Whitney; M G Neubauer; J M Green; V L McDonald; G J Todaro; M Shoyab
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

7.  Cumulative effect of double-site mutations of human epidermal growth factor on receptor binding.

Authors:  S R Campion; M K Geck; S K Niyogi
Journal:  J Biol Chem       Date:  1993-01-25       Impact factor: 5.157

8.  Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues.

Authors:  M F Press; C Cordon-Cardo; D J Slamon
Journal:  Oncogene       Date:  1990-07       Impact factor: 9.867

9.  Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) beta. Different strategies of IL-1 production and processing in monocytes and keratinocytes.

Authors:  H Mizutani; R Black; T S Kupper
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

10.  Pattern of expression of c-erbB-2 oncoprotein in human fetuses.

Authors:  P Quirke; A Pickles; N L Tuzi; O Mohamdee; W J Gullick
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640

View more
  62 in total

Review 1.  Roles of ErbB-3 and ErbB-4 in the physiology and pathology of the mammary gland.

Authors:  K L Carraway; C A Carraway; K L Carraway
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-04       Impact factor: 2.673

Review 2.  ErbB receptors and EGF-like ligands: cell lineage determination and oncogenesis through combinatorial signaling.

Authors:  R Pinkas-Kramarski; I Alroy; Y Yarden
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-04       Impact factor: 2.673

Review 3.  ErbB-4: a receptor tyrosine kinase.

Authors:  W Zhou; G Carpenter
Journal:  Inflamm Res       Date:  2002-02       Impact factor: 4.575

4.  A genomewide scan of male sexual orientation.

Authors:  Brian S Mustanski; Michael G Dupree; Caroline M Nievergelt; Sven Bocklandt; Nicholas J Schork; Dean H Hamer
Journal:  Hum Genet       Date:  2005-01-12       Impact factor: 4.132

5.  The extracellular linker of pro-neuregulin-alpha2c is required for efficient sorting and juxtacrine function.

Authors:  Juan C Montero; Ruth Rodríguez-Barrueco; Laura Yuste; Pedro P Juanes; Joana Borges; Azucena Esparís-Ogando; Atanasio Pandiella
Journal:  Mol Biol Cell       Date:  2006-11-15       Impact factor: 4.138

Review 6.  Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.

Authors:  Chao Deng; Bo Pan; Martin Engel; Xu-Feng Huang
Journal:  Psychopharmacology (Berl)       Date:  2013-02-07       Impact factor: 4.530

7.  Neuregulin-1 isoforms are differentially expressed in the intact and regenerating adult rat nervous system.

Authors:  Gabriele Kerber; Robert Streif; Franz-Werner Schwaiger; Georg W Kreutzberg; Gerhard Hager
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

Review 8.  The neu-protein and breast cancer.

Authors:  C R De Potter; A M Schelfhout
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

9.  A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor.

Authors:  E Tzahar; H Waterman; X Chen; G Levkowitz; D Karunagaran; S Lavi; B J Ratzkin; Y Yarden
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

10.  Effects of schizophrenia risk variation in the NRG1 gene on NRG1-IV splicing during fetal and early postnatal human neocortical development.

Authors:  Clare Paterson; Yanhong Wang; Joel E Kleinman; Amanda J Law
Journal:  Am J Psychiatry       Date:  2014-09       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.